“In some jurisdictions, cannabis comes with real freedom. In others, it still comes with real consequences,” said NORML Development Director JM Pedini. “This survey is about capturing that gap — not just what the laws say, but how people actually experience them.”
“These results have significant policy implications, particularly with respect to the use of traditional workplace drug testing. It is high-time to abandon these discriminatory methods in favor of performance testing and fit-for-duty testing, which employ measures to assess whether someone is currently under the influence, whether it be from marijuana on anything else.”
“The status quo is not an option. The Council agrees that a well-regulated market … is a safer market.”
“Patients who take traditional medications do not face punishment in the workplace unless their on-the-job performance is impaired. Patients who consume medical cannabis during their off-hours should be treated equally.”
“While we welcome any easing of federal policies that target and discriminate against cannabis consumers, this particular policy shift appears to be largely opportunistic and not in any way reflective of a broader shift in the federal government’s stance toward those who consume marijuana responsibly.”
According to statewide polling compiled by the campaign, over 80 percent of Idahoans support legalizing medical cannabis access.
NORML Winter ’25/Spring ’26 Intern Tobey MacCachran shares how Ohio lawmakers’ repeal of legalization provisions will impact his healthcare access.
